Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD) - An Early Feasibility Study

NCT05368246 is registered in ClinicalTrials.gov with InnoCon Medical as lead sponsor.

NCT NCT05368246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05368246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD) - An Early Feasibility Study
Lead sponsor
InnoCon Medical
Phase
Not applicable
Overall status
Completed
Start date
February 15, 2022
Completion date
January 15, 2024
Enrollment
80 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bowel disorders functional, fecal incontinence, incontinence, nighttime urinary, nocturia, urge incontinence, urinary frequency more than once at night, urinary incontinence, urinary incontinence, urge